Dm. Bannerman et al., INHIBITION OF NITRIC-OXIDE SYNTHASE DOES NOT PREVENT THE INDUCTION OFLONG-TERM POTENTIATION IN-VIVO, The Journal of neuroscience, 14(12), 1994, pp. 7415-7425
Nitric oxide (NO), a putative intercellular messenger in the CNS, may
be involved in certain forms of synaptic plasticity and learning. This
article reports a series of experiments investigating whether an inhi
bitor of NO synthase, N-omega-nitro-L-arginine methyl ester (L-NAME),
affects long-term potentiation (LTP) in vivo, as the results of recent
in vitro experiments would predict. L-NAME, given as an acute injecti
on at a dose sufficient to inhibit hippocampal NO synthase (>90%), had
no effect on perforant path-dentate gyrus LTP induced by a strongly s
uprathreshold tetanus, but appeared to impair LTP induced by a weak ne
ar-threshold tetanus that may be more physiologically relevant. Howeve
r, subsequent studies revealed that chronic L-NAME treatment (>95% inh
ibition of NO synthase) had no effect upon LTP induction, and that acu
te (but not chronic) treatment resulted in a gradual but significant r
eduction in nontetanized baseline field potentials. The baseline shift
appeared to be of a magnitude sufficient to account for the apparent
impairment of weak tetanus-induced LTP. This possibility was further e
xamined in a two-hemisphere experiment in which the time course of cha
nges in the field EPSP of the nontetanized pathway served as the withi
n-subject control for the tetanized pathway. No impairment of LTP indu
ction was observed; indeed, if anything, there was a trend for greater
potentiation with L-NAME. Because NO has also been implicated in the
control of vasodilation, the effect of L-NAME on cerebrovascular funct
ion was also investigated. Peripheral blood pressure was significantly
increased by L-NAME at the same dose that affected the field EPSP. Lo
cal cerebral glucose utilization was unchanged, while local cerebral b
lood flow decreased significantly in various brain regions, including
the hippocampus, indicating an uncoupling of cerebral metabolism and b
lood flow. Thus, while NO synthase inhibition does not appear to limit
the induction of LTP in vivo, it does reduce the size of baseline fie
ld EPSPs and affect local cerebrovascular function.